for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

NIPRO CORPORATION

8086.T

Latest Trade

1,308.00JPY

Change

-13.00(-0.98%)

Volume

802,100

Today's Range

1,300.00

 - 

1,325.00

52 Week Range

908.00

 - 

1,547.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,321.00
Open
1,322.00
Volume
802,100
3M AVG Volume
18.73
Today's High
1,325.00
Today's Low
1,300.00
52 Week High
1,547.00
52 Week Low
908.00
Shares Out (MIL)
163.10
Market Cap (MIL)
226,498.00
Forward P/E
15.90
Dividend (Yield %)
0.79

Next Event

Dividend For 8086.T - 16.5000 JPY

Latest Developments

More

Nipro to issue unsecured corporate bonds worth 10 bln yen

R&I affirms Nipro's rating at "BBB+" and says stable outlook -R&I

R&I affirms Nipro's rating at "BBB+" and says stable outlook -R&I

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About NIPRO CORPORATION

NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.

Industry

Medical Equipment & Supplies

Contact Info

3-9-3, Honjo-nishi, Kita-ku

OSAKA-SHI, OSK

531-8510

Japan

+81.6.63722331

https://www.nipro.co.jp/

Executive Leadership

Yoshihiko Sano

President, Representative Director

Goichi Miyazumi

Deputy Director of International Business, President of Subsidiary, Director

Yasushi Ohyama

Managing Director, Chief Director of Vascular Product Development Sales, Director of Vascular Business

Takehito Yogo

Managing Director, Chief Director of Business Planning

Kyoetsu Kobayashi

Managing Director, Director of Production Business, Manager of Odate Plant

Key Stats

2.33 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2018

0.4K

2019

0.4K

2020

0.4K

2021(E)

0.5K
EPS (JPY)

2018

71.150

2019

73.680

2020

-75.300

2021(E)

83.193
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.51
Price To Book (MRQ)
1.41
Price To Cash Flow (TTM)
7.28
Total Debt To Equity (MRQ)
376.93
LT Debt To Equity (MRQ)
261.85
Return on Investment (TTM)
-2.12
Return on Equity (TTM)
-1.40

Latest News

Latest News

BRIEF-Yuki Gosei Kogyo says NIPRO to sell 5 pct stake in co to Nagase

* Says its shareholder, NIPRO Corp, will sell 5 percent stake(1.1 million shares) in the company to Nagase & Co Ltd , at the price of 350 yen per share, for 384.5 million yen in total, on March 30

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up